Fibromyalgia Clinical Study Information


The Resonator™ device uses electro-magnetic stimulation in order to relieve symptoms of a disorder or disease.

 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

 
 
 
 
   
   

Study Design

Procedure Groups

There will be three procedure groups in this study, with an equal number of subjects assigned to each of the three groups, as follows:

  • Test group A: Subjects in Test Group A will receive the actual procedure with the Resonator™ device activated, employing „Protocol A.‟
  • Test group B: Subjects in Test Group B will receive the actual procedure with the Resonator™ device activated, employing „Protocol B.‟
  • Placedbo (control) group: Subjects in the placebo group will receive a „sham‟ procedure with the Resonator™ device not activated.

Apart from the distinction of whether or not the subject receives procedures with the Resonator™ device activated (Protocol A or Protocol B), all subjects and the investigative parties will adhere to all phases of the entire protocol design.

Subject Procedure Group Randomization

Upon study qualification, subjects will be randomized to one of the three procedure groups via a randomized block design with varying block sizes of three and six subjects. In each block, one-third of the subjects will be randomly assigned to each of Procedure Groups A, B, and C.

Randomization will be attained using computer generation sequence methodology, insuring that the randomization methodology and the generated allocation sequence is concealed from the investigator and subjects.

Concealment will be insured as follows:

  1. Each computer generated randomization sequence is unique and will therefore not be able to be replicated.
  2. Randomization will occur to either Procedure Group A, B, or C rather than to one of the two test procedure groups and to the placebo group. Only the study Sponsor will know which letter group assignment corresponds to which procedure group. The Sponsor will not reveal this information to any source (investigators, subjects or study Monitor) until the final data set has been analyzed.

Once a subject has qualified for and enrolled in the study, the PI will contact the study Monitor who will act as the central source for providing sequential subject group assignment.


 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.